Research paperDiscovery of novel anti-angiogenesis agents. Part 6: Multi-targeted RTK inhibitors

Add time:08/19/2019    Source:sciencedirect.com

Angiogenesis is modulated by a multitude of pro-angiogenic factors including VEGFR-2, Tie-2, and EphB4. Moreover, their crosstalk also had been well elaborated. We have identified several diarylurea-based VEGFR-2 inhibitors as potential anti-angiogenesis agents. As a continuation to our previous research, two series of diaryl malonamide and diaryl thiourea derivatives have been developed as multiplex VEGFR-2/Tie-2/EphB4 inhibitors. Interestingly, the biological evaluation indicated that several compounds bearing trifluoromethyl or trifluoromethoxyl exhibited promising multiplex inhibition against angiogenesis-related VEGFR-2, Tie-2, and EphB4. The representative compound (18a) displayed both potent multi-targeted RTK inhibition and considerable antiproliferative activities against human umbilical vein endothelial cells (EA.hy926). These results will contribute to the discovery of novel muti-targeted anti-angiogenesis agents.

We also recommend Trading Suppliers and Manufacturers of 6-TRIFLUOROMETHOXY-PYRIDIN-3-YLAMINE (cas 135900-33-3). Pls Click Website Link as below: cas 135900-33-3 suppliers

Prev:Research paperDiscovery of novel anti-angiogenesis agents. Part 8: Diaryl thiourea bearing 1H-indazole-3-amine as multi-target RTKs inhibitors
Next:Structural modifications of quinolone-3-carboxylic acids with anti-HIV activity)